CLINICAL_TRIALS
trial_result
· 2024-04-10
Clinical Trial Update: Ketamine for Postoperative Avoidance of Depressive Symptoms: The K-PASS Feasibility Trial [Phase 3]
Summary
This Phase 3 feasibility trial (K-PASS) evaluated whether ketamine can prevent depressive symptoms after surgery; results were posted on 2024-04-10.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Washington University School of Medicine | Conditions: Postoperative Depression | Phase 3 | Status: COMPLETED | Results posted: 2024-04-10